$55M equity rights offering
Company: Core Scientific
What the later record shows
Delivered late
The up-to-$55 million equity rights offering was consummated on the Effective Date. That date fell after the January 5, 2024 target because the plan was only confirmed on January 16, 2024. The exact date is not stated.
“on January 16, 2024, the Bankruptcy Court entered an order confirming the Plan of Reorganization (the “Confirmation Order”)”
2024-03-12 · Core Scientific 10-K filed 2024-03-13 View cached copy (2026-08-31)Live source ↗
“the Company commenced an equity rights offering in accordance therewith on November 20, 2023, which was consummated on the Effective Date”
2024-05-05 · Core Scientific 424B3 filed 2024-05-06 View cached copy (2026-08-31)Live source ↗
Checked November 16, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
A $55 million equity rights offering, anticipated at $0.34 per share, is to provide liquidity upon emergence.
Source (primary)
core-scientific 8-K exhibit (d31518dex991.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-15)Live source ↗
Quote: “$55 million equity rights offering and $80 million exit facility (of which $40 million is new money) provide liquidity upon emergence”
How we checked this
Additional evidence
confirms core-scientific 8-K exhibit (d31518dex991.htm)
Quote: “$55 million equity rights offering and $80 million exit facility (of which $40 million is new money) provide liquidity upon emergence”
confirms Core Scientific 10-K filed 2024-03-13
Quote: “on January 16, 2024, the Bankruptcy Court entered an order confirming the Plan of Reorganization (the “Confirmation Order”)”
confirms Core Scientific 424B3 filed 2024-05-06
Quote: “the Company commenced an equity rights offering in accordance therewith on November 20, 2023, which was consummated on the Effective Date”